Firm Extends 16-Year Streak on GCR’s Ranking of World’s Most Elite Antitrust Teams
Latham earned a top three ranking in every antitrust category, including merger control, cartel, non-cartel, and private litigation.
Brendan McShane advises market-leading companies at the intersection of antitrust law and business innovation, with a particular focus on class action defense and government investigations.
Mr. McShane draws on extensive experience in precedent-setting matters across the consumer products; entertainment, sports and media (ESM); and hospitality spaces to help clients resolve disputes in high-exposure, complex antitrust and unfair competition matters.
His experience spans claims involving:
He regularly resolves litigation at the motion-to-dismiss, class certification, and summary judgment phases — and, if necessary, litigates cases through trial. His advocacy spans matters in both the class action and business-to-business contexts.
Mr. McShane also helps clients navigate civil and criminal investigations brought by the US Department of Justice (DOJ), the US Federal Trade Commission (FTC), and state attorneys general.
A recognized leader within the antitrust bar, Mr. McShane is an active member of the Bar Association of San Francisco, the Association of Business Trial Lawyers, and the American Bar Association’s Antitrust Law Section.
He has served on the firm’s Recruiting, Pro Bono, and Legal Professional & Paralegal Committees.
Mr. McShane maintains an active pro bono practice, including representing clients in Special Immigrant Juvenile Status petitions through the International Refugee Assistance Project, section 1983 matters, and Violence Against Women Act (VAWA) petitions.
Mr. McShane’s experience includes representing:
Latham earned a top three ranking in every antitrust category, including merger control, cartel, non-cartel, and private litigation.
Global Competition Review’s renowned annual rankings celebrate Latham’s banner year of legal innovation and history-making work.
Latham recognized for wins for Ferrellgas and United Therapeutics.